Literature DB >> 23247602

Ischemic stroke in patients on oral anticoagulant therapy for a cardioembolic risk factor: always due to cardioembolism?

Gino Gialdini1, Alberto Chiti, Marta Gennaro, Giovanni Orlandi, Ubaldo Bonuccelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23247602     DOI: 10.1007/s10072-012-1273-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

Review 1.  American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.

Authors:  Jack Hirsh; Valentin Fuster; Jack Ansell; Jonathan L Halperin
Journal:  Circulation       Date:  2003-04-01       Impact factor: 29.690

2.  Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies.

Authors:  R G Hart; L A Pearce; V T Miller; D C Anderson; J F Rothrock; G W Albers; E Nasco
Journal:  Cerebrovasc Dis       Date:  2000 Jan-Feb       Impact factor: 2.762

Review 3.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

4.  Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study.

Authors:  Carmine Marini; Federica De Santis; Simona Sacco; Tommasina Russo; Luigi Olivieri; Rocco Totaro; Antonio Carolei
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

5.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.